Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
NOT YET RECRUITING
NCT07212998
PHASE3

Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) Trial

Sponsor: Jason Sperry

View on ClinicalTrials.gov

Summary

The Plasma Resuscitation Early for Evaluating Volume and Endotheliopathy of Thermal Injury (PREEVEnT) trial will be a 6-year (4-year enrollment), open label, phase-3, multi-center, early in-hospital phase randomized trial utilizing burn centers from within the LITES network and will enroll approximately 750 injured adult patients who have suffered large 2nd or 3rd degree thermal burns on at least 20% of their body surface requiring burn resusciation. The objective is to determine if initiating plasma resuscitation as soon as possible upon arrival to an emergency department or burn unit is the most effective resuscitation for those who have experienced large thermal burns and significantly reduces the morbidity and mortality attributable to post-injury complications as compared to standard in-hospital resuscitation practice.

Key Details

Gender

All

Age Range

18 Years - 75 Years

Study Type

INTERVENTIONAL

Enrollment

750

Start Date

2026-04

Completion Date

2030-05

Last Updated

2026-03-13

Healthy Volunteers

No

Interventions

BIOLOGICAL

Plasma

urgent release early plasma resuscitation following burn/thermal injury

BIOLOGICAL

Standard care

Standard resuscitation as dictated by institutional protocol

Locations (1)

University of Pittsburgh

Pittsburgh, Pennsylvania, United States